Arnaud Gos
University of Geneva
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Arnaud Gos.
Nucleic Acids Research | 2012
Emily Dimmer; Rachael P. Huntley; Yasmin Alam-Faruque; Tony Sawford; Claire O'Donovan; María Martín; Benoit Bely; Paul Browne; Wei Mun Chan; Ruth Eberhardt; Michael Gardner; Kati Laiho; D Legge; Michele Magrane; Klemens Pichler; Diego Poggioli; Harminder Sehra; Andrea H. Auchincloss; Kristian B. Axelsen; Marie-Claude Blatter; Emmanuel Boutet; Silvia Braconi-Quintaje; Lionel Breuza; Alan Bridge; Elizabeth Coudert; Anne Estreicher; L Famiglietti; Serenella Ferro-Rojas; Marc Feuermann; Arnaud Gos
The GO annotation dataset provided by the UniProt Consortium (GOA: http://www.ebi.ac.uk/GOA) is a comprehensive set of evidenced-based associations between terms from the Gene Ontology resource and UniProtKB proteins. Currently supplying over 100 million annotations to 11 million proteins in more than 360 000 taxa, this resource has increased 2-fold over the last 2 years and has benefited from a wealth of checks to improve annotation correctness and consistency as well as now supplying a greater information content enabled by GO Consortium annotation format developments. Detailed, manual GO annotations obtained from the curation of peer-reviewed papers are directly contributed by all UniProt curators and supplemented with manual and electronic annotations from 36 model organism and domain-focused scientific resources. The inclusion of high-quality, automatic annotation predictions ensures the UniProt GO annotation dataset supplies functional information to a wide range of proteins, including those from poorly characterized, non-model organism species. UniProt GO annotations are freely available in a range of formats accessible by both file downloads and web-based views. In addition, the introduction of a new, normalized file format in 2010 has made for easier handling of the complete UniProt-GOA data set.
Human Mutation | 2008
Yum Lina Yip; Maria Livia Famiglietti; Arnaud Gos; Paula D. Duek; Fabrice David; Alain Gateau; Amos Marc Bairoch
UniProtKB/Swiss‐Prot (http://beta.uniprot.org/uniprot; last accessed: 19 October 2007) is a manually curated knowledgebase providing information on protein sequences and functional annotation. It is part of the Universal Protein Resource (UniProt). The knowledgebase currently records a total of 32,282 single amino acid polymorphisms (SAPs) touching 6,086 human proteins (Release 53.2, 26 June 2007). Nearly all SAPs are derived from literature reports using strict inclusion criteria. For each SAP, the knowledgebase provides, apart from the position of the mutation and the resulting change in amino acid, information on the effects of SAPs on protein structure and function, as well as their potential involvement in diseases. Presently, there are 16,043 disease‐related SAPs, 14,266 polymorphisms, and 1,973 unclassified variants recorded in UniProtKB/Swiss‐Prot. Relevant information on SAPs can be found in various sections of a UniProtKB/Swiss‐Prot entry. In addition to these, cross‐references to human disease databases as well as other gene‐specific databases, are being added regularly. In 2003, the Swiss‐Prot variant pages were created to provide a concise view of the information related to the SAPs recorded in the knowledgebase. When compared to the information on missense variants listed in other mutation databases, UniProtKB/Swiss‐Prot further records information on direct protein sequencing and characterization including posttranslational modifications (PTMs). The direct links to the Online Mendelian Inheritance in Man (OMIM) database entries further enhance the integration of phenotype information with data at protein level. In this regard, SAP information in UniProtKB/Swiss‐Prot complements nicely those existing in genomic and phenotypic databases, and is valuable for the understanding of SAPs and diseases. Hum Mutat 29(3), 361–366, 2008.
Human Genetics | 1999
Haiming Chen; Colette Rossier; Michael A. Morris; Hamish S. Scott; Arnaud Gos; Amos Marc Bairoch
Abstract. To contribute to the creation of a transcription map of human chromosome 21 (HC21) and to the identification of genes that may be involved in the pathogenesis of Down syndrome, exon trapping was performed from HC21-specific cosmids covering the entire chromosome. More than 700 exons have been identified to date. One such exon, hmc01a06, maps to YAC 831B6 which contains marker D21Z1 (alphoid repeats) and had previously been localized to the pericentromeric region of HC21. Northern-blot analysis revealed a 2.5-kb mRNA species strongly and exclusively expressed in the testis. We cloned the corresponding full-length cDNA, which encodes a predicted polypeptide of 551 amino acids with at least two potential transmembrane domains and a tyrosine phosphatase motif. The cDNA has sequence homology to chicken tensin, bovine auxilin and rat cyclin-G associated kinase (GAK). The entire polypeptide sequence also has significant homology to tumor suppressor PTEN/MMAC1 protein. We termed this novel gene/protein TPTE (transmembrane phosphatase with tensin homology). Polymerase chain reaction amplification, fluorescent in situ hybridization, Southern-blot and sequence analysis using monochromosomal somatic cell hybrids showed that this gene has highly homologous copies on HC13, 15, 22, and Y, in addition to its HC21 copy or copies. The estimated minimum number of copies of the TPTE gene in the haploid human genome is 7 in male and 6 in female. Zoo-blot analysis showed that TPTE is conserved between humans and other species. The biological function of the TPTE gene is presently unknown; however, its expression pattern, sequence homologies, and the presence of a potential tyrosine phosphatase domain suggest that it may be involved in signal transduction pathways of the endocrine or spermatogenetic function of the testis. It is also unknown whether all copies of TPTE are functional or whether some are pseudogenes. TPTE is, to our knowledge, the gene located closest to the human centromeric sequences.
Human Mutation | 1997
Jean Villard; Walter Reith; Emmanuèle Barras; Arnaud Gos; Michael A. Morris; Peter J. Van den Elsen; Bernard Mach
MHC class II deficiency is a severe primary immunodeficiency characterised by the absence of major histocompatibility complex class II (MHC‐II) gene expression. It is genetically heterogeneous and can result from defects in at least four different trans‐acting regulatory genes required for transcription of MHC‐II genes. One of these genes has recently been shown to encode a novel DNA binding protein called RFX5, which is one subunit of a heteromeric protein complex (RFX) that binds to the promoters of MHC‐II genes. We have characterised the mutations in all four patients known to harbour a defect in the RFX5 gene and have mapped this new human disease gene to chromosome 1 band q21, a region frequently exhibiting chromosomal aberrations in a variety of preneoplastic and neoplastic diseases. Hum Mutat 10:430–435, 1997.
Journal of Medical Genetics | 1997
M. C. Bittencourt; Michael A. Morris; J. Chabod; Arnaud Gos; B. Lamy; Florence Fellmann; E. Plouvier; P. Herve; P. Tiberghien
Uniparental isodisomy is defined as the inheritance of two copies of the same parental chromosome and can result in defects when it produces homozygosity for a recessive mutation or in the presence of imprinting. We describe the detection of a chromosome 6 uniparental isodisomy in a 9 year old girl, discovered during a search for an HLA identical sib. HLA typing, erythrocyte phenotyping, and genotypes of microsatellite polymorphisms were compatible with a paternal isodisomy of chromosome 6, with normal biparental origin of the other chromosomes. Paternal cells were not responsive to the patients cells in mixed lymphocyte cultures. This fortuitous detection of a chromosome 6 isodisomy suggests that cases of chromosome 6 UPD may not be deleterious and may therefore go undetected.
Human Mutation | 2014
Maria Livia Famiglietti; Anne Estreicher; Arnaud Gos; Jerven T. Bolleman; Sebastien Gehant; Lionel Breuza; Alan Bridge; Sylvain Poux; Nicole Redaschi; Lydie Bougueleret; Ioannis Xenarios
During the last few years, next‐generation sequencing (NGS) technologies have accelerated the detection of genetic variants resulting in the rapid discovery of new disease‐associated genes. However, the wealth of variation data made available by NGS alone is not sufficient to understand the mechanisms underlying disease pathogenesis and manifestation. Multidisciplinary approaches combining sequence and clinical data with prior biological knowledge are needed to unravel the role of genetic variants in human health and disease. In this context, it is crucial that these data are linked, organized, and made readily available through reliable online resources. The Swiss‐Prot section of the Universal Protein Knowledgebase (UniProtKB/Swiss‐Prot) provides the scientific community with a collection of information on protein functions, interactions, biological pathways, as well as human genetic diseases and variants, all manually reviewed by experts. In this article, we present an overview of the information content of UniProtKB/Swiss‐Prot to show how this knowledgebase can support researchers in the elucidation of the mechanisms leading from a molecular defect to a disease phenotype.
American Journal of Medical Genetics | 1997
Stephan Eliez; Michael A. Morris; Sophie Dahoun-Hadorn; C. Dawn DeLozier‐Blanchet; Arnaud Gos; Pierre Sizonenko
We describe a 17-year-old girl with mild Prader-Willi syndrome (PWS) due to 15q11-q13 deletion. The deletion occurred on a paternal chromosome 15 already involved in a translocation, t(Y;15)(q12;p11), the latter being present in five other, phenotypically normal individuals in three generations. This appears to be the first case of PWS in which the causative 15q11-q13 deletion occurred on a chromosome involved in a familial translocation, but with breakpoints considerably distal to those of the familial rearrangement. The translocation could predispose to additional rearrangements occurring during meiosis and/or mitosis or, alternatively, the association of two cytogenetic anomalies on the same chromosome could be fortuitous.
Receptors & Channels | 1995
S. Valera; F. Talabot; R. J. Evans; Arnaud Gos; Michael A. Morris; G. N. Buell
Receptors & Channels | 1998
G. N. Buell; F. Talabot; Arnaud Gos; J. Lorenz; E. Lai; Michael A. Morris
Nature Genetics | 1995
Haiming Chen; Roman Chrast; Colette Rossier; Arnaud Gos; Jun Kudoh; Akiko Yamaki; Nobuaki Shindoh; Hideto Maeda; Shinsei Minoshima